1. Home
  2. News
  3. GSK plc
  4. GSK: Director Declaration
More GSK plc news
GSK plcLSE: GSK

GSK: Director Declaration

Jun 24, 2025 at 10:00 AM EDT · Issued by GSK plc

On 6ix: 6ix.com/news/director-declaration-248

Watch GSK's latest call↗GSK (LSE:GSK) Q2 2026 Earnings Call · Replay · Jul 28Read the transcript of GSK (LSE:GSK) Q2 2026 Earnings Call↗

GSK plc

Director Declaration

The Company announces that Wendy Becker, Non-Executive Director and Chair of the Remuneration Committee, was appointed Chair of the Board of Sony Group Corporation (Sony) with effect from 24 June 2025. Prior to this appointment, Wendy was Vice Chair of the Board of Sony.

V A Whyte

Company Secretary

24 June 2025

GSK plc on 6ix

Earlier from GSK

  • FDA approves Benlysta (belimumab) Autoinjector for children with active lupus nephritisJun 24, 2025
  • Replacement - Director/PDMR ShareholdingJun 23, 2025
  • Replacement RNS: Linerixibat file accepted by EMAJun 23, 2025
  • GSK Submits Arexvy for adults 18+ with EMAJun 23, 2025
  • Arexvy filed in Japan for 18-49 at increased riskJun 20, 2025

Later from GSK

  • GSK completes acquisition of efimosfermin for SLDJul 7, 2025
  • Hansa Biopharma appoints Dr Richard Philipson as Chief Medical OfficerJul 8, 2025
  • GSK begins shipping influenza vaccine doses for the 2025-26 flu seasonJul 10, 2025
  • GSK submits Arexvy for adults 18-49 AIR to FDAJul 14, 2025
  • GSK’s Shingrix Fully Liquid FDA approvalJul 17, 2025
All GSK news releases↗

Follow GSK into a list and get an email when it puts out news.

Follow GSK
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer